Hydrocodone 5/325mg – The Complete Medical Guide

Hydrocodone 5/325mg is a moderate-strength opioid analgesic combining 5mg hydrocodone bitartrate (Schedule II controlled substance) with 325mg acetaminophen. This lower-dose formulation is commonly prescribed for acute pain management when non-opioid medications prove inadequate. As one of the most frequently prescribed pain medications in the U.S., it requires careful clinical consideration due to its addiction potential and acetaminophen toxicity risks.

Hydrocodone 5-325mg

Hydrocodone 5/325mg is a prescription painkiller that combines hydrocodone (5 mg), an opioid analgesic, with acetaminophen (325 mg), a widely used non-opioid pain reliever. This combination provides effective relief for moderate to severe pain, such as that caused by injury, surgery, or chronic conditions.

Hydrocodone works by altering the brain’s perception of pain, while acetaminophen enhances the overall pain-relieving effects. Hydrocodone 5/325mg is commonly prescribed for short-term use but should only be taken under the guidance of a healthcare professional due to the risk of dependence, overdose, and side effects.

Medical Uses & Indications

FDA-Approved Uses

 Moderate to moderately severe acute pain
 Short-term pain management (≤14 days typically)
 Dental pain (Post-procedure)
 Musculoskeletal injuries

Key Clinical Features

• Potency: 5mg hydrocodone ≈ 5mg oral morphine
• Onset: 20-30 minutes (oral administration)
• Duration: 4-6 hours of analgesia
• DEA Classification: Schedule II controlled substance
• Acetaminophen Content: Below daily maximum threshold

Pharmacology & Effects

Mechanism of Action

• Hydrocodone: μ-opioid receptor agonist
• Acetaminophen: Central COX inhibition

Therapeutic Effects

Effective pain relief within 30 minutes
Mild sedation/relaxation
Antipyretic effect (from acetaminophen)

Risk Profile

• Lower abuse potential than higher-dose formulations
• Still carries addiction risk with prolonged use
• Hepatotoxicity possible at high acetaminophen doses

Dosing & Administration

Standard Dosing

• Adults: 1-2 tablets every 4-6 hours as needed
• Maximum Daily:

• Hydrocodone: 40mg (8 tablets)

• Acetaminophen: 3,250mg (10 tablets)

Special Populations

Critical Safety Notes

 Limit to shortest effective duration
 Avoid concurrent alcohol use
 Monitor for opioid-naive patients
 Assess addiction risk factors

Safety Profile

Common Side Effects

• Constipation (most common opioid effect)
• Nausea/vomiting
• Dizziness/lightheadedness
• Mild pruritus

Serious Risks

 Respiratory depression (dose-dependent)
 Accidental overdose
 Hepatotoxicity (from acetaminophen)
 Physical dependence

Overdose Management

Dual Toxicity Considerations

• Opioid component: Respiratory depression
• Acetaminophen: Hepatic necrosis

Emergency Protocol

1. Administer naloxone (0.4-2mg IN/IM)

2. Initiate acetylcysteine if APAP >150mg/kg

3. Supportive care

4. Continuous monitoring

Harm Reduction Strategies

1. Prescription limits: ≤7 day supply for acute pain

2. State PDMP checks before prescribing

3. Naloxone co-prescribing for at-risk patients

4. Patient education on proper use/storage

Clinical Alternatives

Non-Opioid Options

• Ibuprofen 400mg + acetaminophen 500mg
• Naproxen 220-550mg
• Diclofenac sodium topical gel

Opioid Alternatives

• Tramadol 50mg (Schedule IV)
• Codeine 30mg + acetaminophen
• Buprenorphine patch (for chronic pain)

Special Considerations